Serum concentration of cardiac Troponin T in patients with hypereosinophilic syndrome treated with imatinib is predictive of adverse outcomes [2] (multiple letters)

Blood

Volumn 102, Issue 9, 2003, Pages 3456-3457

  Pitini, Vincenzo ^a   Arrigo, Carmela ^c   Azzarello, Domenico ^c   La Gattuta, Gaetana ^c   Amata, Cinzia ^c   Righi, Maria ^c   Coglitore, Sebastiano ^c   Tefferi, Ayalew ^b   Pardanani, Animesh ^c  

^a UNIVERSITY OF MESSINA   (Italy)

^b MAYO CLINIC   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; IMATINIB; PROTEIN TYROSINE KINASE INHIBITOR; TROPONIN T;

ADULT; BLOOD LEVEL; CARDIOMYOPATHY; CARDIOTOXICITY; CELL COUNT; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DRUG MEGADOSE; DYSPNEA; ECHOCARDIOGRAPHY; EOSINOPHIL; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE BIOPSY; HEART MUSCLE CELL; HUMAN; HYPEREOSINOPHILIA; LETTER; PATIENT MONITORING; PREDICTION; PRIORITY JOURNAL; SERUM; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 0142183434     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-07-2393     Document Type: Letter

References (0)